Abstract
Economic evaluations are becoming increasingly important tools for assisting in health services decision making. Program managers and other decision makers often need to compare different programs and set priorities for resource allocation. Economic evaluations can be helpful by providing information about the costs and benefits of various alternatives. For evaluations to be comparable, however, they must be conducted by similar methods. Economic evaluation for AIDS prevention and prevention generally is a relatively new concept, and therefore methods for conducting such studies are still being developed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Teutsch S, Haddix A, eds. A Practical Guide to Prevention Effectiveness: Decision and Economic Analysis. Atlanta, Georgia: Centers for Disease Control and Prevention; 1994.
Haddix AC, Teutsch SM, Shaffer PA, Dunet DO, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. New York Oxford University Press; 1996.
Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in Health and Medicine. New York Oxford University Press; 1996.
World Bank. World Development Report 1993: Investing in Health. New York Oxford University Press; 1993.
Holtgrave DR, Qualls NL, Graham JD. Economic evaluation of HIV prevention programs. Annu Rev Public Health 1996; 17:467–488.
Drummond M, Stoddard G, Torrance G. Methods for the Economic Evaluation of Health Care Programmes. New York: Oxford University Press, 1987.
Pinkerton SD, Holtgrave DR. Assessing the cost-effectiveness of HIV prevention interventions: A primer. In Holtgrave DR, ed. Handbook of Economic Evaluation of HIV Prevention, New York: Plenum.
Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. J Acquired Immune Defic Syndr Hum Retrovirol, in press.
Sisk J. The effectiveness of AIDS prevention efforts. The Office of Technology Assessment, 1995.
Mauskopf J, Paul J, Wichman D, White A, Tilson H. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. JAMA 1996; 276(2): 132–138.
Drummond M, Brandt A, Luce B, Rovira J. Standardizing methodologies for economic evaluation in health care. Int J Technol Assessment Health Care 1993; 9(1): 26–36.
Warner K, Luce B. Cost-Benefit and Cost-Effectiveness Analysis in Health Care. Ann Arbor, Michigan: Health Administration Press, 1982.
Weinstein M, Stason W. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 296(13): 716–721.
Phillips KA, Holtgrave D. Using cost-effectiveness/cost-benefit analysis to allocate health resources: A level playing field for prevention? Am J Preventive Med, 1997; 13(11): 18–25.
Ganiats T. Discounting in cost-effectiveness research. Medical Decision Making 1994; 14(3): 298–303.
Krahn M, Gafni A. Discounting in the economic evaluation of health care interventions. Medical Care 1993; 31(5): 403–418.
Sheldon T. Discounting in health care decision-making: Time for a change? J Public Health Med 1992; 14(3): 250–256.
Robinson J. Philosophical origins of the social rate of discount in cost-benefit analysis. The Milbank Q 1990; 68(2): 245–265.
Ganiats T. On sale: Future health care. West J Med 1992; 156: 550–553.
Anonymous. Discounting health care: Only a matter of timing? Lancet 1992; 340: 148-149.
Keeler E, Cretin S. Discounting of life-saving and other nonmonetary effects. Manage Sci 1983; 23: 300–306.
Horowitz J, Carson R. Discounting statistical lives. J Risk Uncertainty 1990; 3: 403–413.
Guinan ME, Farnham PG, Holtgrave DR. Estimating the value of preventing an HIV infection. Am J Preventive Med 1994; 10: 1–4.
Hellinger F. Forecasts of the costs of medical care for persons with HIV: 1991–1995. Inquiry 1992; 29: 356–365.
Hellinger F. The lifetime cost of treating a person with HIV. JAMA 1993; 270: 474–478.
Villari P, Fattore G, Siegle J, Paltiel A, Weinstein M. Economic evaluation of HIV testing among intravenous drug users. Int J Technol Assessment Health Care 1996; 12(2): 336–357.
Phillips KA, Lowe R, Kahn J, Lurie P, Avins A, Ciccarone D. The cost-effectiveness of HIV testing of physicians and dentists in the United States. JAMA 1994; 271(11): 851–858.
Lurie P, Avins A, Phillips KA, Kahn J, Lowe R, Ciccarone D. The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection. JAMA 1994; 272(23): 1832–1838.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Phillips, K.A., Haddix, A., Holtgrave, D.R. (1998). An Overview of Economic Evaluation Methodologies and Selected Issues in Methods Standardization. In: Holtgrave, D.R. (eds) Handbook of Economic Evaluation of HIV Prevention Programs. AIDS Prevention and Mental Health. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1878-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1878-9_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1880-2
Online ISBN: 978-1-4899-1878-9
eBook Packages: Springer Book Archive